您好,欢迎光临有路网!
药理学(第2版)(英文版)
QQ咨询:
有路璐璐:

药理学(第2版)(英文版)

  • 作者:蒋志文
  • 出版社:人民军医出版社
  • ISBN:9787509160350
  • 出版日期:2014年01月01日
  • 页数:264
  • 定价:¥45.00
  • 猜你也喜欢

    分享领佣金
    手机购买
    城市
    店铺名称
    店主联系方式
    店铺售价
    库存
    店铺得分/总交易量
    发布时间
    操作

    新书比价

    网站名称
    书名
    售价
    优惠
    操作

    图书详情

    内容提要
    《高等医药教育教材:药理学(英文版)(第2版)》在第1版的基础上修订而成,作者蒋志文参考多部国外流行的新版药理学教材和专著,吸纳国内药理学教科书之风格,并结合作者从事十多年药理学双语教学之经验,编写的。全书共44章,包括药理学总论4章,传出神经系统用药7章,**神经系统用药8章,心血管系统用药5章,化疗用药11章,激素类**3章,H—受体阻断药、利尿药和呼吸、消化、解热镇痛、缩宫保胎用药各1章。《高等医药教育教材:药理学(英文版)(第2版)》内容新颖、阐述准确,可作为医药卫生本、专科药理学双语教学之用,亦可作为药理学专业工作者自修用书。
    目录
    Chapter 1 Introduction
    Chapter 2 Pharmacokinetics
    Drug absorption
    Drug distribution
    Excretion
    Transformation (metabolism)
    Elimination kinetics of drugs
    The time course of the quantitative change of drug in the body
    Design and optimization of dosage regimens
    Compartment model
    Chapter 3 Pharmacodynamics
    Basic action of drug
    Relation between drug dose and clinical response
    Mechanism of drug action
    Drug and receptor
    Intracellular signal transduction
    Drug—receptor interactions
    Classification of drugs acting on the receptor
    Receptor regulation
    Chapter 4 Factors Affecting the Pharmacological Effects
    Drug
    Body
    Gender
    Genetic factors
    Disease state
    Placebo effects
    Changes of reactivity after long administration
    Chapter 5 General Principle of Efferent Nervous System
    Pharmacology
    Transmitter of efferent nervous system
    Receptors of efferent nervous system
    Effects mediated by α—adrenoceptors
    Effects mediated by cholinergic receptors
    Function of efferent nervous system
    Basic action of efferent nervous system drugs
    Classification of drugs acting on efferent nervous system
    Chapter 6 Cholinoceptor Agonists
    Acetylcholine(ACh)
    M—Cholinoceptor agonists
    Chapter 7 Anticholinesterase and Cholinesterase Reactivators
    Cholinesterase inhibitors
    Reversible cholinesterase inhibitor
    Irreversible cholinesterase inhibitor
    Cholinesterase reactivator
    Chapter 8 Anticholinergic Drugs(Part 1)
    M—cholinoceptor blocking drugs
    Chapter 9 Anticholinergic Drugs (Part 2)
    N—Cholinoceptor blocking drugs
    Depolarizing muscle relaxant
    Chapter 10 Adrenergic Drugs
    Mixed α and β agonists
    α—Receptor agonists
    β— Receptor agonists
    Dopamine receptor agonists
    Chapter 11 Adrenoceptor Blocking Drugs
    α—Adrenoceptor blocking drugs
    β—Receptor blocking drugs
    α, β—Receptor blocker
    Chapter 12 General Anesthetics
    Inhaled anesthetics
    Intravenous anesthetics
    Anesthetics adjuncts
    Chapter 13 Local Anesthetics
    Pharmacodyamics
    Usual local anesthetics
    Clinical use of local anesthetics
    Absorptive action and adverse reaction
    Chapter 14 Sedative—hypnotics
    General introduction
    Benzodiazepines
    Benzodiazepine receptor antagonist
    Other sedative—hypnotics
    Chapter 15 Antiepileptics and Anticonvulsants
    Classification of seizure types
    Antiseizure agents
    Selection and withdrawal of antiepileptic drugs
    Anticonvulsant drugs
    Chapter 16 Antiparkinsonism Drugs
    Chapter 17 Narcotic Analgesics
    General considerations
    Opioid analgesics
    Synthetic analgesic drug
    Opioid antagonists
    The analgesic therapy for pain associated with cancer
    Chapter 18 Antipsychotic Drugs
    Phenothiazines
    Thioxanthene derivatives
    Butyrophenones
    Atypical antipsychotic drugs
    The antimanic drugs
    Antidepressants
    Chapter 19 Antipyretic—analgesic and Antiinflammatory Agents
    General concepts
    Aspirin and sodium salicylate
    Slow acting antirheumatic drugs
    Antigout drugs
    Chapter 20 Central Stimulants
    Corticocerebral stimulants
    Stimulants that mainly stimulate apneustic center in medulla oblongata
    Appendix: Cerebral function protecting drugs
    Chapter 21 Antiarrhythmic Agents
    Cardiac electrophysiology
    Mechanisms responsible for cardiac arrhythmias
    Classification of antiarrhythmic drugs
    Individual antiarrhythmic drugs
    Class Ⅰ.Na+ channel blocker(Ia)
    Class Ⅰ.Na+ channel blocker (Ⅰb)
    Class Ⅰ.Na+ channel blocker (Ⅰc)
    Class Ⅱ.β—receptor blocker
    Class Ⅲ.Drugs for prolonging ADP
    Class Ⅳ.Calcium channel blocker
    Class Ⅴ.Other antiarrhymics
    Chapter 22 Diuretics and Dehydrant Diuretics
    Renal physiology
    High efficacy diuretics (Loop diuretics)
    Moderate efficacy diuretics (thiazides diuretics)
    Low efficacy diuretics (potassium— sparing diuretics)
    Dehydrant (osmotic diuretics)
    Chapter 23 Antihypertensive Drugs
    Classification of hypertension and antihypertensive drugs
    Pharmacotherapeutic concept of hypertension
    Diuretic agents
    Angiotensin Ⅰ converting enzyme inhibitors and angiotensin Ⅱ receptor blockers
    Sympathetic nervous inhibitors
    Calcium antagonists
    Vasodilators
    Chapter 24 Drugs Used in the Treatment of Heart Failure
    Cardiac glycosides
    Other positive inotropic drugs
    Drugs without positive inotropic effects
    Chapter 25 Anti—angina Pectoris Drugs
    Nitrates and nitrites
    β—Adrenergic receptor blockers
    Calcium channel blockers
    Chapter 26 Antihyperlipidemic Agents
    HMG—CoA reductase inhibitors
    Bile—acid—binding resins(cholestyrarnine, cotestipot)
    Fibrates
    Nicotinic acid (Niacin)
    Probucol
    Chapter 27 H—Receptor Blocking Drugs
    H1—Receptor blocking drugs
    H2—Receptor blocking drugs
    Chapter 28 Drugs Affecting the Respiratory System
    Antiasthmatic agents
    Other drugs
    Antitussives
    Expectorants
    Chapter 29 Drugs Acting on Digestive System
    Antipeptic ulcer drugs
    Digestants
    Antiemetics
    Cathartics (Laxatives)
    Antidiarrheal drugs
    Chapter 30 Oxytocics and Tocolytic Drugs
    Oxytocics
    Tocolytic drugs
    Chapter 31 Adrenocortical Hormones
    Glucocorticoid
    Chapter 32 Agents Affecting the Thyroid Gland
    Thyroid hormone
    Antithyroid agents
    Chapter 33 Insulin and Oral Hypoglycemic Agents
    Insulin
    Oral hypoglycemic agents
    Other drugs
    Chapter 34 Introduction to Antibacterial Drugs
    Antibacterial drugs & chemotherapy
    Basic concepts
    Mechanism of action
    Resistance
    Principles of application of antibacterial drugs
    Chapter 35 β—Lactam Antibiotics
    Penicillins
    Natural penicillins
    Semisynthetic penicillins
    Cephalosporins
    Other β—lactam drugs
    Chapter 36 Macrolides, Clindamycin and Vancomycin
    Macrolides
    Clindamycin
    Vancomycin
    Chapter 37 Aminoglycosides
    Individual aminoglycosides
    Chapter 38 Tetracyclines and Chloramphenicols
    Tetracyclines
    Chloramphenicol
    Chapter 39 Synthetic Antimicrobial
    Quinolones
    Sulfonamides and trimethoprim
    Chapter 40 Antifungal Drugs and Antiviral Drugs
    Antifungal drugs
    Antibiotics
    Azoles
    Others
    Antiviral drugs
    Chapter 41 Antituberculous Drugs
    First—line drugs
    Second—line drugs
    Principles of antituberculous chemotherapy
    Chapter 42 Antimalarial Drugs
    Malarial life cycle and sites of drug action
    Antimalarial drugs
    Chapter 43 Antiamebic Drugs
    Chapter 44 Cancer Chemotherapy
    Mechanisms of action and classification of anticancer drugs
    Kinetics of cell cycle
    Individual anticancer drugs
    Antibiotics
    Inorganic metal complex
    Drugs that interfere with protein synthesis
    Miscellaneous anticancer drugs

    与描述相符

    100

    北京 天津 河北 山西 内蒙古 辽宁 吉林 黑龙江 上海 江苏 浙江 安徽 福建 江西 山东 河南 湖北 湖南 广东 广西 海南 重庆 四川 贵州 云南 西藏 陕西 甘肃 青海 宁夏 新疆 台湾 香港 澳门 海外